325 related articles for article (PubMed ID: 36831308)
21. Core binding factor in the early avian embryo: cloning of Cbfbeta and combinatorial expression patterns with Runx1.
Bollerot K; Romero S; Dunon D; Jaffredo T
Gene Expr Patterns; 2005 Dec; 6(1):29-39. PubMed ID: 16033710
[TBL] [Abstract][Full Text] [Related]
22. Core Binding Factor β Plays a Critical Role During Chondrocyte Differentiation.
Park NR; Lim KE; Han MS; Che X; Park CY; Kim JE; Taniuchi I; Bae SC; Choi JY
J Cell Physiol; 2016 Jan; 231(1):162-71. PubMed ID: 26058470
[TBL] [Abstract][Full Text] [Related]
23. Differential requirements for HIV-1 Vif-mediated APOBEC3G degradation and RUNX1-mediated transcription by core binding factor beta.
Du J; Zhao K; Rui Y; Li P; Zhou X; Zhang W; Yu XF
J Virol; 2013 Feb; 87(3):1906-11. PubMed ID: 23175372
[TBL] [Abstract][Full Text] [Related]
24. Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction.
Cunningham L; Finckbeiner S; Hyde RK; Southall N; Marugan J; Yedavalli VR; Dehdashti SJ; Reinhold WC; Alemu L; Zhao L; Yeh JR; Sood R; Pommier Y; Austin CP; Jeang KT; Zheng W; Liu P
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14592-7. PubMed ID: 22912405
[TBL] [Abstract][Full Text] [Related]
25. HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfaces.
Hultquist JF; McDougle RM; Anderson BD; Harris RS
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1543-51. PubMed ID: 22725134
[TBL] [Abstract][Full Text] [Related]
26. Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder.
Satpathy AT; Briseño CG; Cai X; Michael DG; Chou C; Hsiung S; Bhattacharya D; Speck NA; Egawa T
Blood; 2014 May; 123(19):2968-77. PubMed ID: 24677539
[TBL] [Abstract][Full Text] [Related]
27. Core binding factor β (CBFβ) is retained in the midbody during cytokinesis.
Lopez-Camacho C; van Wijnen AJ; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2014 Oct; 229(10):1466-74. PubMed ID: 24648201
[TBL] [Abstract][Full Text] [Related]
28. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
Engel ME; Hiebert SW
Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
[TBL] [Abstract][Full Text] [Related]
29. Cbfbeta interacts with Runx2 and has a critical role in bone development.
Kundu M; Javed A; Jeon JP; Horner A; Shum L; Eckhaus M; Muenke M; Lian JB; Yang Y; Nuckolls GH; Stein GS; Liu PP
Nat Genet; 2002 Dec; 32(4):639-44. PubMed ID: 12434156
[TBL] [Abstract][Full Text] [Related]
30. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells.
Klunker S; Chong MM; Mantel PY; Palomares O; Bassin C; Ziegler M; Rückert B; Meiler F; Akdis M; Littman DR; Akdis CA
J Exp Med; 2009 Nov; 206(12):2701-15. PubMed ID: 19917773
[TBL] [Abstract][Full Text] [Related]
31. Structure and Biophysics of CBFβ/RUNX and Its Translocation Products.
Tahirov TH; Bushweller J
Adv Exp Med Biol; 2017; 962():21-31. PubMed ID: 28299648
[TBL] [Abstract][Full Text] [Related]
32. RUNX1 as a Novel Molecular Target for Breast Cancer.
Ariffin NS
Clin Breast Cancer; 2022 Aug; 22(6):499-506. PubMed ID: 35599145
[TBL] [Abstract][Full Text] [Related]
33. Charged Amino Acid-rich Leucine Zipper-1 (Crlz-1) as a Target of Wnt Signaling Pathway Controls Pre-B Cell Proliferation by Affecting Runx/CBFβ-targeted VpreB and λ5 Genes.
Choi SY; Park SK; Yoo HW; Pi JH; Kang CJ
J Biol Chem; 2016 Jul; 291(29):15008-19. PubMed ID: 27226553
[TBL] [Abstract][Full Text] [Related]
34. RUNX1 is required for oncogenic
Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Vif-Mediated Degradation of APOBEC3G through Competitive Binding of Core-Binding Factor Beta.
Miyagi E; Welbourn S; Sukegawa S; Fabryova H; Kao S; Strebel K
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941780
[TBL] [Abstract][Full Text] [Related]
36. Runx2 in normal tissues and cancer cells: A developing story.
Blyth K; Vaillant F; Jenkins A; McDonald L; Pringle MA; Huser C; Stein T; Neil J; Cameron ER
Blood Cells Mol Dis; 2010 Aug; 45(2):117-23. PubMed ID: 20580290
[TBL] [Abstract][Full Text] [Related]
37. The Association Between Runx Signaling and Craniofacial Development and Disease.
Yamashiro T; Kurosaka H; Inubush T
Curr Osteoporos Rep; 2022 Feb; 20(1):120-126. PubMed ID: 34931296
[TBL] [Abstract][Full Text] [Related]
38. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
Miller JD; Stacy T; Liu PP; Speck NA
Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
[TBL] [Abstract][Full Text] [Related]
39. RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML.
Hyde RK; Liu P; Friedman AD
Adv Exp Med Biol; 2017; 962():265-282. PubMed ID: 28299663
[TBL] [Abstract][Full Text] [Related]
40. CBFβ enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G.
Miyagi E; Kao S; Yedavalli V; Strebel K
J Virol; 2014 May; 88(9):4839-52. PubMed ID: 24522927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
